Dolobid
Active substance: diflunisal
TABLET, FILM COATED · DIFLUNISAL 250 mg/1
United StatesActive
Marketing holder: INA Pharmaceutics Inc
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- DIFLUNISAL · 250 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-d194-76a8-a669-93b50d931de7,01a1208c-fcac-7139-834f-a47dfd87487b,01a1208e-e36d-7aa3-8d4e-ba3d44f45c7d,01a12090-9746-7bc6-b16d-403ce97f3692,01a12096-98a7-7efe-8bd8-ba1fa2214094;count=7 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 74157-009
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 74157-009 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 74157-009 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 74157-009 · Verified 2026-10-09 · open in source